Amy K. Darke

6.2k total citations
41 papers, 1.6k citations indexed

About

Amy K. Darke is a scholar working on Oncology, Nutrition and Dietetics and Biochemistry. According to data from OpenAlex, Amy K. Darke has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Nutrition and Dietetics and 9 papers in Biochemistry. Recurrent topics in Amy K. Darke's work include Selenium in Biological Systems (9 papers), Antioxidant Activity and Oxidative Stress (9 papers) and Economic and Financial Impacts of Cancer (8 papers). Amy K. Darke is often cited by papers focused on Selenium in Biological Systems (9 papers), Antioxidant Activity and Oxidative Stress (9 papers) and Economic and Financial Impacts of Cancer (8 papers). Amy K. Darke collaborates with scholars based in United States, South Africa and Puerto Rico. Amy K. Darke's co-authors include Phyllis J. Goodman, Ian M. Thompson, Howard L. Parnes, Lori M. Minasian, Catherine M. Tangen, Eric A. Klein, Scott M. Lippman, Frank L. Meyskens, Gary E. Goodman and Charles A. Coltman and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Amy K. Darke

40 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy K. Darke United States	18	400	352	232	219	185	41	1.6k
Fernando Pérez‐Barriocanal Spain	24	201 0.5×	277 0.8×	221 1.0×	611 2.8×	112 0.6×	60	2.0k
İlker Durak Türkiye	25	228 0.6×	170 0.5×	160 0.7×	579 2.6×	89 0.5×	99	2.1k
Mohammad Athar Saudi Arabia	21	223 0.6×	298 0.8×	111 0.5×	722 3.3×	247 1.3×	77	2.3k
Young Youl Hyun South Korea	20	163 0.4×	165 0.5×	100 0.4×	305 1.4×	49 0.3×	86	1.8k
Etsuko Kobayashi Japan	25	236 0.6×	476 1.4×	162 0.7×	652 3.0×	101 0.5×	77	1.9k
Elisabetta Bigagli Italy	25	157 0.4×	139 0.4×	121 0.5×	770 3.5×	246 1.3×	69	2.3k
Benedetta Bendinelli Italy	24	159 0.4×	130 0.4×	262 1.1×	288 1.3×	212 1.1×	70	1.6k
Peng Yu China	29	484 1.2×	670 1.9×	107 0.5×	919 4.2×	518 2.8×	106	2.7k
Julie Martin Canada	25	208 0.5×	397 1.1×	86 0.4×	339 1.5×	46 0.2×	82	1.8k
Yue Ma China	28	155 0.4×	115 0.3×	160 0.7×	779 3.6×	278 1.5×	88	2.0k

Countries citing papers authored by Amy K. Darke

Since Specialization

Citations

This map shows the geographic impact of Amy K. Darke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy K. Darke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy K. Darke more than expected).

Fields of papers citing papers by Amy K. Darke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy K. Darke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy K. Darke. The network helps show where Amy K. Darke may publish in the future.

Co-authorship network of co-authors of Amy K. Darke

This figure shows the co-authorship network connecting the top 25 collaborators of Amy K. Darke. A scholar is included among the top collaborators of Amy K. Darke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy K. Darke. Amy K. Darke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tawfik, Bernard, Kate Watabayashi, Ruth C. Carlos, et al.. (2025). Addressing Challenges in Research Aimed at Reducing Financial Toxicity Among Cancer Patients and Caregivers: An Example From the CREDIT Study (SWOG S1912CD). Cancer Control. 32. 2935762517–2935762517. 1 indexed citations

Watabayashi, Kate, Deborah Delaney, Ruth C. Carlos, et al.. (2023). Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinics. JNCI Cancer Spectrum. 7(5). 10 indexed citations

Vaidya, Riha, Amy K. Darke, Krishna S. Gunturu, et al.. (2023). Examining uptake of electronic patient reported outcomes (ePRO) in a prospective study of immune-related adverse events (IR-AEs).. JCO Oncology Practice. 19(11_suppl). 368–368. 1 indexed citations

Trivedi, Meghna S., Joseph M. Unger, Dawn L. Hershman, et al.. (2023). Abstract PD8-06: Incidence of Acute and Persistent Clinically Meaningful Chemotherapy Induced Peripheral Neuropathy in Patients with Early-Stage Breast Cancer Receiving Taxane Therapy: SWOG S1714 (NCT# 03939481). Cancer Research. 83(5_Supplement). PD8–6. 1 indexed citations

Trivedi, Meghna S., Joseph M. Unger, Dawn L. Hershman, et al.. (2023). Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714.. Journal of Clinical Oncology. 41(16_suppl). 12003–12003. 3 indexed citations

Hui, David, Amy K. Darke, Katherine A. Guthrie, et al.. (2021). Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials. JCO Oncology Practice. 18(4). e442–e451. 5 indexed citations

Shankaran, Veena, Joseph M. Unger, Amy K. Darke, et al.. (2021). S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients. JNCI Journal of the National Cancer Institute. 114(3). 372–380. 39 indexed citations

Darke, Amy K., Katherine A. Guthrie, Jeff A. Sloan, et al.. (2021). Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials. JCO Oncology Practice. 17(8). e1246–e1257. 14 indexed citations

Shankaran, Veena, Joseph M. Unger, Amy K. Darke, Dawn L. Hershman, & Scott D. Ramsey. (2020). Design, data linkage, and implementation considerations in the first cooperative group led study assessing financial outcomes in cancer patients and their informal caregivers. Contemporary Clinical Trials. 95. 106037–106037. 5 indexed citations

10.

Christen, William G., Amy K. Darke, John Michael Gaziano, et al.. (2020). Age‐related macular degeneration in a randomized trial of selenium and vitamin E in men: the Select Eye Endpoints (SEE) study (SWOG S0000B). Acta Ophthalmologica. 99(2). e285–e287. 3 indexed citations

11.

Chan, June M., Amy K. Darke, Kathryn L. Penney, et al.. (2016). Selenium- or Vitamin E–Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1050–1058. 47 indexed citations

12.

Kristal, Alan R., Amy K. Darke, J. Steven Morris, et al.. (2014). Baseline Selenium Status and Effects of Selenium and Vitamin E Supplementation on Prostate Cancer Risk. JNCI Journal of the National Cancer Institute. 106(3). djt456–djt456. 180 indexed citations

13.

Brasky, Theodore M., Amy K. Darke, Xiaoling Song, et al.. (2013). Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial. JNCI Journal of the National Cancer Institute. 105(15). 1132–1141. 196 indexed citations

14.

Moinpour, Carol M., Amy K. Darke, Gary Donaldson, et al.. (2012). Health-Related Quality-of-Life Findings for the Prostate Cancer Prevention Trial. JNCI Journal of the National Cancer Institute. 104(18). 1373–1385. 12 indexed citations

15.

Klein, Eric A., Ian M. Thompson, Catherine M. Tangen, et al.. (2012). Vitamin E and the risk of prostate cancer: Updated results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. Journal of Clinical Oncology. 30(5_suppl). 7–7. 18 indexed citations

16.

Baker, Stuart G., Amy K. Darke, Paul F. Pinsky, Howard L. Parnes, & Barnett S. Kramer. (2010). Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial. Biostatistics. 11(3). 413–418. 6 indexed citations

17.

Lucia, M. Scott, Amy K. Darke, Phyllis J. Goodman, et al.. (2008). Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention. Cancer Prevention Research. 1(3). 167–173. 72 indexed citations

18.

Lucia, M. Scott, Jonathan I. Epstein, Phyllis J. Goodman, et al.. (2007). Finasteride and High-Grade Prostate Cancer in the Prostate Cancer Prevention Trial. JNCI Journal of the National Cancer Institute. 99(18). 1375–1383. 174 indexed citations

19.

Moinpour, Carol M., Amy K. Darke, Gary Donaldson, et al.. (2007). Longitudinal Analysis of Sexual Function Reported by Men in the Prostate Cancer Prevention Trial. JNCI Journal of the National Cancer Institute. 99(13). 1025–1035. 64 indexed citations

20.

Darke, Amy K. & J. Patrick Megonigal. (2003). Control of sediment deposition rates in two mid-Atlantic Coast tidal freshwater wetlands. Estuarine Coastal and Shelf Science. 57(1-2). 255–268. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact